BioCatalystWatch
PRAXWorkspace / PRAX / OverviewCompany library
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. (PRAX)

Website

Price
Market cap
Next catalystDec 27, 2026Relutrigine — SCN2A/SCN8A-DEE · Regulatory decisionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Elsunersen

SCN2A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Relutrigine

NaV channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

Relutrigine

NaV channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Ulixacaltamide

T-type calcium channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

vormatrigine (PRAX-628)

NaV channels

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Relutrigine

NaV channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Relutrigine

NaV channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

Elsunersen

SCN2A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Ulixacaltamide

T-type calcium channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

vormatrigine (PRAX-628)

NaV channels

PreINDP1P2P3FilingApproved

Other pipelines

vormatrigine (PRAX-628)

NaV channels

PreINDP1P2P3FilingApproved
PRAX-110

NaV1.8 × NaV1.2 × NaV1.6 × NaV1.7

Upcoming / outlook

  • Timing and evidence

PRAX-206

KCNT1

Upcoming / outlook

PRAX-215

NaV1.2 × NaV1.6 × NaV1.7 × NaV1.8

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ulixa eTDDS

Upcoming / outlook

KCNQ2

PRAX-090

SYNGAP1

PreINDP1P2P3FilingApproved

History / paused

Relutrigine

NaV channels

Ulixacaltamide

T-type calcium channels

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PRAX PR & News

PR & News

PRAX SEC archive